SG11201805635RA - Human milk products useful in pre- and post-operative care - Google Patents
Human milk products useful in pre- and post-operative careInfo
- Publication number
- SG11201805635RA SG11201805635RA SG11201805635RA SG11201805635RA SG11201805635RA SG 11201805635R A SG11201805635R A SG 11201805635RA SG 11201805635R A SG11201805635R A SG 11201805635RA SG 11201805635R A SG11201805635R A SG 11201805635RA SG 11201805635R A SG11201805635R A SG 11201805635RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- human milk
- prolacta
- california
- city
- Prior art date
Links
- 210000004251 human milk Anatomy 0.000 title abstract 4
- 235000020256 human milk Nutrition 0.000 title abstract 4
- 230000002980 postoperative effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000047875 Pica hudsonia Species 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/02—Preservation of milk or milk preparations by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Water Supply & Treatment (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 1111111101111011101010111110101111101110111010111011101101101111101111011111 International Bureau ... .... ..Yjd (10) International Publication Number (43) International Publication Date .... ...rr,' WO 2017/117409 Al 6 July 2017 (06.07.2017) WI P0 I P CT (51) International Patent Classification: (71) Applicant: PROLACTA BIOSCIENCE, INC. [US/US]; A23C 9/20 (2006.01) A23C 9/152 (2006.01) 757 Baldwin Park Blvd., City of Industry, California A23C 9/00 (2006.01) 91746 (US). (21) International Application Number: (72) Inventors: ELSTER, Scott; c/o Prolacta Bioscience, Inc., PCT/US2016/069250 757 Baldwin Park Blvd., City of Industry, California 91746 (US). FOURNELL, Joseph; c/o Prolacta Bios- (22) International Filing Date: 29 December 2016 (29.12.2016) cience, Inc., 757 Baldwin Park Blvd., City of Industry, California 91746 (US). (25) Filing Language: English (74) Agents: FULLER, Alyson C. et al.; Cooley LLP, 1299 (26) Publication Language: English Pennsylvania Avenue, NW, Suite 700, Washington, Dis- trict of Columbia 20004 (US). (30) Priority Data: 62/273,243 30 December 2015 (30.12.2015) US (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, [Continued on next page] (54) Title: HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE (57) : The present disclosure relates to human milk composi- FIGURE 1 tions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to 'A`\\"111'1 , ,‘, V'tk feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery. . I II r, i< Ito . i < Di t4 . .ti SEPARATE PROTEIN 1 , , (*STAIN 14UMAig LIPID = SUSI' %. \ ION B 3. OP I IONA i , II , I I IF, St., Si' SI() 11 C:r © 7r • Ir •••• Il Il Ir •••• Il © ei C WO 2017/117409 Al 1#11101111O111111 IIMIMMEMOM DIEMEN HOHOMEHOIS BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. — as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) — as to the applicant's entitlement to claim the priority of (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, — TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, the earlier application (Rule 4.17(iii)) Published: with international search report (Art. 21(3))
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562273243P | 2015-12-30 | 2015-12-30 | |
PCT/US2016/069250 WO2017117409A1 (en) | 2015-12-30 | 2016-12-29 | Human milk products useful in pre- and post-operative care |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201805635RA true SG11201805635RA (en) | 2018-07-30 |
Family
ID=59225761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201805635RA SG11201805635RA (en) | 2015-12-30 | 2016-12-29 | Human milk products useful in pre- and post-operative care |
Country Status (8)
Country | Link |
---|---|
US (3) | US11344041B2 (en) |
EP (1) | EP3397064A4 (en) |
JP (3) | JP7356221B2 (en) |
AU (3) | AU2016381834B2 (en) |
CA (1) | CA3009667C (en) |
IL (2) | IL303044A (en) |
SG (1) | SG11201805635RA (en) |
WO (1) | WO2017117409A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2967094T (en) | 2013-03-13 | 2021-01-14 | Prolacta Bioscience Inc | High fat human milk products |
WO2017117409A1 (en) | 2015-12-30 | 2017-07-06 | Prolacta Bioscience, Inc. | Human milk products useful in pre- and post-operative care |
US20210106626A1 (en) * | 2018-09-13 | 2021-04-15 | Original Biological Technology Co., Ltd. | Nutrition formula milk powder for infants after congenital heart disease surgery or non-cardiac surgery and other critically illinfants in intensive care, and method of using the same |
WO2021146561A1 (en) * | 2020-01-17 | 2021-07-22 | Prolacta Bioscience, Inc. | Feeding protocol for optimal growth of preterm infants |
CA3205754A1 (en) * | 2021-01-22 | 2022-07-28 | Biranchi Patra | Topical human milk formulations |
WO2022204463A1 (en) * | 2021-03-26 | 2022-09-29 | Prolacta Bioscience, Inc. | Methods of treatment for failure to thrive |
Family Cites Families (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2567898A (en) | 1945-03-19 | 1951-09-11 | Separator Ab | Method of standardizing cream |
US3946113A (en) | 1972-08-21 | 1976-03-23 | Economics Laboratory, Inc. | Continuous separating and standardizing of milk |
SE380422B (en) | 1974-03-07 | 1975-11-10 | Alfa Laval Ab | PROCEDURE FOR SEPARATION OF LIQUID MILK PRODUCTS |
DE3040171C2 (en) | 1980-10-24 | 1986-05-22 | Max-Josef Dr.-Ing. Zürich Schönhuber | Data registration system for recording the data of certain quantities of goods, in particular milk deliveries |
US4362697A (en) | 1981-04-20 | 1982-12-07 | Miles Laboratories, Inc. | Homogeneous specific binding assay test device having copolymer enhancing substance |
JPS6133895U (en) | 1984-07-31 | 1986-03-01 | 東レ株式会社 | heating roller device |
SE451791B (en) | 1984-09-11 | 1987-11-02 | Alfa Laval Food & Dairy Eng | SET AND PLANT FOR PREPARING MILK WITH LOW BACTERIA CONTENT |
US4772262A (en) | 1985-04-16 | 1988-09-20 | Natural Technologies, Inc. | Portable electric breast pump |
US4762822A (en) | 1985-08-08 | 1988-08-09 | Ettinger Anna C | Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides |
US5310893A (en) | 1986-03-31 | 1994-05-10 | Hoffmann-La Roche Inc. | Method for HLA DP typing |
JPS6467141A (en) | 1987-09-08 | 1989-03-13 | Kougakushiya Kk | Method for removing various germs and somatic cell from cow's milk and apparatus therefor |
NZ228690A (en) | 1988-04-13 | 1991-10-25 | Snow Brand Milk Products Co Ltd | Continuous production of cheese curds from ultrafiltrated milk |
US6020015A (en) | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
US5064674A (en) | 1989-01-13 | 1991-11-12 | Immunopath Profile, Inc. | Hypoallergenic milk products and process of making |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
US5334822A (en) | 1990-05-21 | 1994-08-02 | Universal Computer Technologies Inc. | Method and system for inventoring a distributed plurality of items on a supply |
DE4018468A1 (en) | 1990-06-08 | 1991-12-12 | Ultrakust Electronic Gmbh | METHOD AND DEVICE FOR TAKING A REPRAESENTATIVE MILK SAMPLE |
US5972337A (en) | 1990-11-01 | 1999-10-26 | Cancer Research Fund Of Contra Costa | 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein |
ATE170559T1 (en) | 1991-05-31 | 1998-09-15 | Genentech Inc | TREATMENT OF HIV-ASSOCIATED IMMUNE THROMBOPENIA PURPURA |
US5169766A (en) | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
FR2681312A1 (en) | 1991-09-16 | 1993-03-19 | Francais Prod Ind Cfpi | LUBRICATING AND DISINFECTING SOLUTION FOR TRANSPORTING CHAIN OF CONTAINERS IN THE AGRO-FOOD INDUSTRY AND METHOD FOR ITS IMPLEMENTATION |
HRP930935A2 (en) | 1992-06-11 | 1994-12-31 | Astra Ab | New dna sequences |
US6056978A (en) | 1992-06-16 | 2000-05-02 | Stolle Milk Biologics, Inc. | Use of hyperimmune milk to prevent suppression of T-lymphocyte production |
US5256437A (en) | 1992-06-19 | 1993-10-26 | Pall Corporation | Product and process of making sterile milk through dynamic microfiltration |
WO1994009651A1 (en) | 1992-10-30 | 1994-05-11 | Cancer Research Fund Of Contra Costa | Anti-diarrheic product and method of treating rotavirus-associated infection |
JP3150504B2 (en) | 1993-02-26 | 2001-03-26 | 雪印乳業株式会社 | Low lactose dairy product and method for producing the same |
DK169510B1 (en) | 1993-05-13 | 1994-11-14 | Apv Pasilac As | Plant and method of treating milk |
DE4326665C2 (en) | 1993-08-09 | 1995-07-13 | Biotest Pharma Gmbh | Process for sterile filtration of milk |
US5340603A (en) | 1993-08-30 | 1994-08-23 | Abbott Laboratories | Nutritional product for human infants having chronic lung disease |
US5670196A (en) | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
US5707678A (en) | 1995-04-12 | 1998-01-13 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
US5983198A (en) | 1996-04-23 | 1999-11-09 | Novus International, Inc. | Integrated system monitoring use of materials, controlling and monitoring delivery of materials and providing automated billing of delivered materials |
US5798266A (en) | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
US6194009B1 (en) | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
US6652900B2 (en) | 1997-03-14 | 2003-11-25 | Tetra Laval Holdings & Finance S.A. | Method and plant for producing a sterile milk product |
SE519853E (en) | 1997-06-19 | 2005-03-29 | Tetra Laval Holdings & Finance | Method of making sterile skim milk |
US6017511A (en) | 1997-05-30 | 2000-01-25 | Resolution Pharmaceuticals Inc. | Glycopeptide-chelator conjugates |
GB9713597D0 (en) | 1997-06-28 | 1997-09-03 | Sec Dep Of The Home Department | Improvements in and relating to forensic identification |
US6846298B1 (en) | 1997-07-25 | 2005-01-25 | Bristol-Myers Squibb Company | Blood product delivery system |
US6004288A (en) | 1998-11-24 | 1999-12-21 | Hochstedler; Judy R. | Breast pump |
NL1010829C2 (en) | 1998-12-16 | 2000-06-19 | Prolion Bv | Device and method for milking animals and a pollution meter. |
DE69904257T2 (en) | 1999-01-20 | 2003-04-17 | N.V. Nutricia, Zoetermeer | infant formula |
WO2000043550A2 (en) | 1999-01-21 | 2000-07-27 | Wayne State University | Method and apparatus for measuring factors in mammary fluids |
US20010049096A1 (en) | 1999-03-23 | 2001-12-06 | Stephen J. Brown | Sample identification with analyte determination |
US6294206B1 (en) | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
FI110752B (en) | 1999-05-25 | 2003-03-31 | Novatreat Oy | A method for treating colostrum |
DK174656B1 (en) | 1999-06-04 | 2003-08-11 | Apv Pasilac As | Process and plant for the treatment of milk |
US6183803B1 (en) | 1999-06-11 | 2001-02-06 | Biosante Pharmaceuticals, Inc. | Method for processing milk |
US6780987B1 (en) | 1999-12-10 | 2004-08-24 | Trustees Of The Tufts College | β-cap73 control of normal and abnormal cell migration |
US20020155445A1 (en) | 1999-12-16 | 2002-10-24 | Jarvik Jonathan W. | Methods and products for peptide based DNA sequence identification and analysis |
US6670124B1 (en) | 1999-12-20 | 2003-12-30 | Stemcyte, Inc. | High throughput methods of HLA typing |
CA2672076A1 (en) | 2000-03-01 | 2001-09-07 | Caridianbct, Inc. | Extracorporeal blood processing information management system |
US6737096B2 (en) | 2000-03-29 | 2004-05-18 | Tetra Laval Holdings & Finance S.A. | Method and apparatus for producing a sterile milk product |
JP2002068998A (en) | 2000-08-29 | 2002-03-08 | Meiji Milk Prod Co Ltd | Composition for preventing occurrence of fatty liver accompanied by transintestine nutrition and intraveneous nutrition |
US20040047856A1 (en) | 2000-11-15 | 2004-03-11 | Williams Charles Edward | Colorstrum-based composition |
US20030152942A1 (en) | 2001-05-09 | 2003-08-14 | Lance Fors | Nucleic acid detection in pooled samples |
US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
US20100268658A1 (en) | 2001-05-14 | 2010-10-21 | Prolacta Bioscience | Method for collecting, testing and distributing milk |
US20070098863A1 (en) | 2005-09-23 | 2007-05-03 | Prolacta Bioscience, Inc. | Method for collecting, testing and distributing milk |
US20070203802A1 (en) | 2005-09-23 | 2007-08-30 | Prolacta Bioscience, Inc. | Method for collecting, testing and distributing milk |
US6866994B2 (en) | 2001-05-30 | 2005-03-15 | Neomatrix, Llc | Noninvasive intraductal fluid diagnostic screen |
US20030093171A1 (en) | 2001-07-19 | 2003-05-15 | Creative Edge Design Group, Ltd. | Flexible label printing assembly |
US6875459B2 (en) | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
FI115752B (en) | 2002-05-14 | 2005-07-15 | Valio Oy | A process for use in the manufacture of a milk product having a low lactose or lactose content |
US6910594B2 (en) | 2002-11-19 | 2005-06-28 | The First Years Inc. | Method and apparatus for storing milk |
US7951410B2 (en) | 2003-04-14 | 2011-05-31 | Mead Johnson Nutrition Company | Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid |
US7867541B2 (en) | 2003-04-14 | 2011-01-11 | Mead Johnson Nutrition Company | Compositions and methods of formulation for enteral formulas containing sialic acid |
PL1638416T3 (en) | 2003-06-23 | 2013-09-30 | Nestec Sa | Use of a nutritional formula for optimal gut barrier function |
WO2005000040A1 (en) | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
NZ527434A (en) | 2003-08-07 | 2006-03-31 | Fonterra Co Operative Group | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese |
WO2005051088A2 (en) | 2003-11-12 | 2005-06-09 | Abbott Laboratories | Iron-containing human milk fortifier with improved antimicrobial properties |
WO2005035557A2 (en) | 2003-10-14 | 2005-04-21 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
CA2557927A1 (en) | 2004-03-04 | 2005-09-15 | Htl High-Tech Lipids Ltd. | Structured triglycerides and emulsions comprising same |
US20050214358A1 (en) | 2004-03-23 | 2005-09-29 | Riken | Composition for promoting development of nervous system |
EP1637043A1 (en) | 2004-09-17 | 2006-03-22 | Medela Holding AG | Human milk fortifiers and methods for their production |
CN101014856B (en) | 2004-09-10 | 2012-06-27 | 美德乐控股公司 | Method for analysing and treating human milk and system therefore |
US20080187619A1 (en) | 2004-09-10 | 2008-08-07 | Medela Holding Ag | Human Milk Fortifiers and Methods for Their Production |
US20060115558A1 (en) | 2004-11-30 | 2006-06-01 | Jean-Claude Lamothe | Method of production and control of animal derived food products and derivatives thereof |
CA2537452C (en) | 2005-03-09 | 2013-12-24 | Abbott Laboratories | Concentrated human milk fortifier liquid |
US20060233915A1 (en) | 2005-04-15 | 2006-10-19 | Bristol-Myers Squibb Company | Liquid nutritional product to supplement human milk |
DE602006016444D1 (en) | 2005-07-01 | 2010-10-07 | Nutricia Nv | BABY FOOD WITH HYDROLIZED PROTEINS |
BRPI0616323A2 (en) | 2005-09-20 | 2011-06-14 | Prolacta Bioscience Inc | Method for determining whether a donated mammary fluid was obtained from a specific individual |
EP2063722B1 (en) | 2006-08-30 | 2017-05-03 | Prolacta Bioscience, Inc. | Methods of obtaining sterile milk and compositions thereof |
ES2633922T3 (en) | 2006-11-29 | 2017-09-26 | Prolacta Bioscience, Inc. | Compositions of human milk and methods for preparing and using them |
CA2706723C (en) | 2006-12-08 | 2015-05-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
US20100119617A1 (en) * | 2007-03-29 | 2010-05-13 | The Hospital For Sick Children | Multi-nutrient milk fortifier |
US20080254165A1 (en) | 2007-04-12 | 2008-10-16 | Rashid Patel | Novel manufacturing process for milk acid |
US20090181848A1 (en) | 2007-07-06 | 2009-07-16 | Ep Minerals, Llc | Crystalline silica-free diatomaceous earth blended filter aids and methods of manufacturing the same |
WO2009068549A1 (en) | 2007-11-26 | 2009-06-04 | Nestec S.A. | Age-tailored nutrition system for infants |
US20100069716A1 (en) | 2008-09-12 | 2010-03-18 | Yem Chin | Flexible guide conduit |
JP2010126495A (en) | 2008-11-28 | 2010-06-10 | Morinaga Milk Ind Co Ltd | Powder to be added to mother's milk |
ES2527959T3 (en) | 2008-12-02 | 2015-02-02 | Prolacta Bioscience, Inc. | Permeate compositions of human milk and methods for making and using them |
WO2011144221A1 (en) | 2010-05-18 | 2011-11-24 | N.V. Nutricia | Preterm milk formula |
WO2012030764A2 (en) * | 2010-08-30 | 2012-03-08 | Neolac, Inc. | Human milk preparation |
SG10201707519PA (en) | 2010-12-31 | 2017-10-30 | Abbott Lab | Neutral human milk oligosaccharides to promote growth of beneficial bacteria |
US8563611B2 (en) | 2011-03-17 | 2013-10-22 | Women's & Children's Health Research Institute | Methods and compositions for promoting the respiratory development of an infant |
PT2739157T (en) | 2011-08-03 | 2018-01-09 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
US10639319B2 (en) * | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
CN102511557B (en) * | 2011-12-29 | 2015-06-17 | 内蒙古伊利实业集团股份有限公司 | Liquid infant milk for newborn to six-month-old infant and production method thereof |
US20140272936A1 (en) * | 2013-03-13 | 2014-09-18 | Prolacta Bioscience | Adulteration testing of human milk |
PT2967094T (en) | 2013-03-13 | 2021-01-14 | Prolacta Bioscience Inc | High fat human milk products |
WO2016109659A1 (en) | 2014-12-30 | 2016-07-07 | Prolacta Bioscience, Inc. | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
EP3282857A4 (en) | 2015-04-15 | 2018-12-12 | Prolacta Bioscience, Inc. | Human milk compositions and methods of making and using same |
WO2017117409A1 (en) | 2015-12-30 | 2017-07-06 | Prolacta Bioscience, Inc. | Human milk products useful in pre- and post-operative care |
US20210106626A1 (en) * | 2018-09-13 | 2021-04-15 | Original Biological Technology Co., Ltd. | Nutrition formula milk powder for infants after congenital heart disease surgery or non-cardiac surgery and other critically illinfants in intensive care, and method of using the same |
-
2016
- 2016-12-29 WO PCT/US2016/069250 patent/WO2017117409A1/en active Application Filing
- 2016-12-29 US US16/067,241 patent/US11344041B2/en active Active
- 2016-12-29 SG SG11201805635RA patent/SG11201805635RA/en unknown
- 2016-12-29 IL IL303044A patent/IL303044A/en unknown
- 2016-12-29 EP EP16882669.1A patent/EP3397064A4/en active Pending
- 2016-12-29 JP JP2018534083A patent/JP7356221B2/en active Active
- 2016-12-29 CA CA3009667A patent/CA3009667C/en active Active
- 2016-12-29 AU AU2016381834A patent/AU2016381834B2/en active Active
- 2016-12-29 IL IL260327A patent/IL260327B2/en unknown
-
2021
- 2021-07-29 JP JP2021124107A patent/JP7389087B2/en active Active
- 2021-09-03 AU AU2021225228A patent/AU2021225228B2/en active Active
- 2021-12-22 US US17/559,284 patent/US12004528B2/en active Active
-
2023
- 2023-07-12 AU AU2023204614A patent/AU2023204614A1/en active Pending
- 2023-09-27 JP JP2023164166A patent/JP2023178306A/en active Pending
-
2024
- 2024-05-09 US US18/659,554 patent/US20240292854A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL260327A (en) | 2018-08-30 |
US20190021357A1 (en) | 2019-01-24 |
JP2019505203A (en) | 2019-02-28 |
EP3397064A1 (en) | 2018-11-07 |
AU2016381834A1 (en) | 2018-06-28 |
JP7389087B2 (en) | 2023-11-29 |
AU2021225228A1 (en) | 2021-09-30 |
AU2023204614A1 (en) | 2023-08-03 |
JP7356221B2 (en) | 2023-10-04 |
IL260327B1 (en) | 2023-06-01 |
JP2023178306A (en) | 2023-12-14 |
CA3009667A1 (en) | 2017-07-06 |
US11344041B2 (en) | 2022-05-31 |
JP2021176325A (en) | 2021-11-11 |
WO2017117409A1 (en) | 2017-07-06 |
IL303044A (en) | 2023-07-01 |
US12004528B2 (en) | 2024-06-11 |
US20220183308A1 (en) | 2022-06-16 |
US20240292854A1 (en) | 2024-09-05 |
EP3397064A4 (en) | 2019-10-30 |
AU2016381834B2 (en) | 2021-09-23 |
AU2021225228B2 (en) | 2023-05-25 |
CA3009667C (en) | 2024-03-26 |
IL260327B2 (en) | 2023-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201805635RA (en) | Human milk products useful in pre- and post-operative care | |
SG11201804373VA (en) | Compositions and methods for immunooncology | |
SG11201809082WA (en) | Nlrp3 modulators | |
SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
SG11201811432WA (en) | Rna for cancer therapy | |
SG11201807195VA (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
SG11201811151PA (en) | Extracellular vesicle comprising a fusion protein having fc binding capacity | |
SG11201811150WA (en) | Ev-mediated delivery of binding protein-small molecule conjugates | |
SG11201811564QA (en) | Methods of treating ovarian cancer | |
SG11201907056XA (en) | Compositions and methods for the treatment of hemoglobinopathies | |
SG11201900163PA (en) | Macrocycle kinase inhibitors | |
SG11201901364VA (en) | Engineered target specific nucleases | |
SG11201804161VA (en) | Compositions comprising bacterial strains | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
SG11201805162VA (en) | Plasmid constructs for heterologous protein expression and methods of use | |
SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
SG11201808592PA (en) | Method for selection of high m6p recombinant proteins | |
SG11201807809XA (en) | A transient commensal microorganism for improving gut health | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
SG11201806852PA (en) | Protein purification | |
SG11201804770QA (en) | Method and arrangement for recovery of salt |